Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data
出版年份 2017 全文链接
标题
Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data
作者
关键词
Bone fracture, Dipeptidyl peptidase-4 inhibitors, Germany, Type 2 diabetes
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 8, Pages 2421-2428
出版商
Springer Nature
发表日期
2017-04-29
DOI
10.1007/s00198-017-4051-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes – A systematic review and meta-analysis
- (2016) Jil Mamza et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK
- (2016) I. Kyvernitakis et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
- (2016) Karel Kostev et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials
- (2016) Jianying Fu et al. Scientific Reports
- Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care
- (2015) Wolfgang Rathmann et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture
- (2015) L. Jacob et al. OSTEOPOROSIS INTERNATIONAL
- Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider
- (2014) I. Kyvernitakis et al. OSTEOPOROSIS INTERNATIONAL
- Antidiabetic therapy effects on bone metabolism and fracture risk
- (2013) A. Montagnani et al. DIABETES OBESITY & METABOLISM
- Review article: a comparison of glucagon-like peptides 1 and 2
- (2012) P. Janssen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus
- (2011) Ji-Hyun Kim et al. CLINICAL ENDOCRINOLOGY
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies
- (2011) H. Becher et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Bone metabolism in type 2 diabetes and role of thiazolidinediones
- (2011) Peter Vestergaard Current Opinion in Endocrinology Diabetes and Obesity
- Four-month treatment with GLP-2 significantly increases hip BMD
- (2009) Dennis B. Henriksen et al. BONE
- Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
- (2009) Bernardo Nuche-Berenguer et al. CALCIFIED TISSUE INTERNATIONAL
- Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
- (2009) M Silvina Molinuevo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
- (2007) Chizumi Yamada et al. ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now